Asthma

HomePatientsLung Disease Week at the ATS2013Asthma ▶ General Information About Asthma
General Information About Asthma

Asthma Week

The inflammation that underlies asthma most prominently impacts the airways of the lungs. Over time, this inflammation leads to changes that result in narrowing and obstruction of these airways, blocking the flow of air and making it more difficult for patients to breathe. This obstruction is associated with exaggerated constriction in response to cold air, exercise or chemical triggers (a phenomenon known as “hyperresponsiveness”) and tends to improve with administration of medications that relax and open the airways (inhaled bronchodilators). Another prominent feature of the inflammation seen in asthma is that it is frequently intermittent, brought on by triggers such as viral illnesses and exposure to airborne allergens. This can lead to variable and episodic symptoms and increase the risk for asthma exacerbations, or “attacks.”

The diagnosis of asthma is typically first considered when patients experience characteristic symptoms of wheezing, cough, chest tightness or shortness of breath. Methods often employed to diagnose asthma include a detailed medical history and physical examination, as well as breathing tests (spirometry) to document airflow obstruction that reverses with a short-acting bronchodilator. Depending on the patient’s history, other tests including a chest X-ray and allergy tests may be considered.

Treatment of asthma focuses on controlling airway inflammation and relieving acute narrowing (constriction) of the airways when it occurs. A number of different drugs are considered to be controller agents, including inhaled corticosteroids, leukotriene modifiers and long-acting beta-agonists. All patients with persistent asthma require at least one controller medication, while also employing short-acting inhaled bronchodilators (such as albuterol) when episodic constriction and obstruction occur. Education about avoidance of triggers and appropriate medication use are also important, as is involving all members of the care team in a comprehensive management approach.


Four Facts About Asthma and Allergies

  1. More than 25 million children (1 in 11) and adults (1 in 12) live with asthma, making it one of the most common and costly diseases. 

  2. Each year, over 3000 US asthma deaths occur. Low income and minority children bear the heaviest burden of asthma, including death.

  3. An estimated 50 million Americans suffer from all types of allergies (1 in 5 Americans) including indoor/outdoor, food & drug, latex, insect, skin and eye allergies.

  4. Allergy is the 5th leading chronic disease in the U.S. among all ages, and the 3rd most common chronic disease among children under 18 years old.